Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14463511 | 0.78 | ALDH1A1 (0.49) | ALDH1A1KDM4EGAAMAPTSMN1; SMN2 | |
| SCHEMBL5237110 | 0.78 | ALDH1A1 (0.49) | ALDH1A1KDM4EGAAMAPTSMN1; SMN2 | |
| SCHEMBL19359381 | 0.77 | RIPK1 (0.39) | CYP1A2CYP3A4RIPK1 | |
| Hydrochloric Acid SCHEMBL5240143 | 0.77 | ALDH1A1 (0.47) | ALDH1A1KDM4EGAAMAPTSMN1; SMN2 | |
| SCHEMBL12747483 | 0.74 | MME (0.32) | — | |
| SCHEMBL8297545 | 0.74 | SRD5A1 (0.32) | SRD5A1 | |
| SCHEMBL12747475 | 0.73 | MME (0.35) | — | |
| SCHEMBL14179036 | 0.73 | — | — | |
| SCHEMBL24046395 | 0.72 | RIPK1 (0.35) | CYP1A2CYP3A4RIPK1 | |
| SCHEMBL8556280 | 0.71 | PIK3CD (0.35) | MAPTKMT2ASRD5A1TSHRCRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827906-B2 | Adeno-associated virus (AAV) clade f vector and uses therefor | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2023-11-28 | — | — | US | disclosed |
| US-11827906-B2 | Adeno-associated virus (AAV) clade f vector and uses therefor | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2023-11-28 | — | — | US | disclosed |
| US-20230287451-A1 | NOVEL AAV CAPSIDS AND COMPOSITIONS CONTAINING SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-09-14 | — | — | US | disclosed |
| US-20230287451-A1 | NOVEL AAV CAPSIDS AND COMPOSITIONS CONTAINING SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-09-14 | — | — | US | disclosed |
| US-20230279394-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | NOVARTIS AG (CH) | 2023-09-07 | — | — | US | disclosed |
| US-20230265459-A1 | Compositions Useful in Treatment of Spinal Muscular Atrophy | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-08-24 | — | — | US | disclosed |
| US-20230265459-A1 | Compositions Useful in Treatment of Spinal Muscular Atrophy | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-08-24 | — | — | US | disclosed |
| US-20230190966-A1 | COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-06-22 | — | — | US | disclosed |
| US-20230190966-A1 | COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-06-22 | — | — | US | disclosed |
| US-11578341-B2 | Compositions useful in treatment of spinal muscular atrophy | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2023-02-14 | — | — | US | disclosed |
| US-20230040603-A1 | COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-02-09 | — | — | US | disclosed |
| US-20230002788-A1 | AAV3B VARIANTS WITH IMPROVED PRODUCTION YIELD AND LIVER TROPISM | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-01-05 | — | — | US | disclosed |
| US-20220204990-A1 | NOVEL AAV CAPSIDS AND COMPOSITIONS CONTAINING SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2022-06-30 | — | — | US | disclosed |
| US-20210123073-A1 | NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS HAVING REDUCED CAPSID DEAMIDATION AND USES THEREFOR | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2021-04-29 | — | — | US | disclosed |
| US-20200407750-A1 | NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS HAVING REDUCED CAPSID DEAMIDATION AND USES THEREFOR | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2020-12-31 | — | — | US | disclosed |
| US-20200390888-A1 | NOVEL AAV MEDIATED INFLUENZA VACCINES | JANSSEN BIOTECH, INC. | 2020-12-17 | — | — | US | disclosed |
| US-10786568-B2 | AAV mediated influenza vaccines | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2020-09-29 | — | — | US | disclosed |
| US-20200056159-A1 | NOVEL ADENO-ASSOCIATED VIRUS (AAV) CLADE F VECTOR AND USES THEREFOR | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210123073-A1 | NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS HAVING REDUCED CAPSID DEAMIDATION AND USES THEREFOR | ASNS, GLUL, USE1 | ALDH1A1 2267/4885KDM4E 3785/4885GAA 1323/4885 |
| US-20230279394-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | HBB, HBG2, HBZ | ALDH1A1 1514/4885KDM4E 1403/4885GAA 107/4885 |
| US-20230040603-A1 | COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS | GALC, GBA1, GLA | ALDH1A1 1820/4885KDM4E 3987/4885GAA 4/4885 |
| US-20200056159-A1 | NOVEL ADENO-ASSOCIATED VIRUS (AAV) CLADE F VECTOR AND USES THEREFOR | VSIG8, ASNS, FARSB | ALDH1A1 2133/4885KDM4E 3076/4885GAA 2543/4885 |
| US-20220204990-A1 | NOVEL AAV CAPSIDS AND COMPOSITIONS CONTAINING SAME | ELAVL1, ELAVL3, ANKRD54 | ALDH1A1 2502/4885KDM4E 2995/4885GAA 1171/4885 |
| US-20230265459-A1 | Compositions Useful in Treatment of Spinal Muscular Atrophy | SMN1; SMN2, SRP68, HNRNPH1 | ALDH1A1 3543/4885KDM4E 4250/4885GAA 521/4885 |
| US-20230190966-A1 | COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS | GALC, GBA1, GBA2 | ALDH1A1 1663/4885KDM4E 4564/4885GAA 5/4885 |
| US-10786568-B2 | AAV mediated influenza vaccines | VSIR, IGLV6-57, VSIG8 | ALDH1A1 2840/4885KDM4E 3988/4885GAA 2852/4885 |
| US-11827906-B2 | Adeno-associated virus (AAV) clade f vector and uses therefor | ASNS, VSIG8, FARSB | ALDH1A1 2197/4885KDM4E 3302/4885GAA 2397/4885 |
| US-20200390888-A1 | NOVEL AAV MEDIATED INFLUENZA VACCINES | VSIR, VSIG8, IGLV6-57 | ALDH1A1 2808/4885KDM4E 3998/4885GAA 2924/4885 |
| US-11578341-B2 | Compositions useful in treatment of spinal muscular atrophy | SMN1; SMN2, SRP68, HNRNPH1 | ALDH1A1 3543/4885KDM4E 4250/4885GAA 521/4885 |
| US-20230287451-A1 | NOVEL AAV CAPSIDS AND COMPOSITIONS CONTAINING SAME | ELAVL1, VSIG8, ELAVL3 | ALDH1A1 2359/4885KDM4E 3214/4885GAA 1400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.